Related by context. All words. (Click for frequent words.) 74 lung prostate 71 colorectal lung 69 ovarian breast 69 prostate colon 68 colorectal prostate 68 hormone refractory prostate 67 breast colorectal 67 colorectal breast 67 uterine ovarian 67 lung pancreatic 67 breast colon 66 ovarian lung 65 metastatic colorectal 65 prostate ovarian 65 cervical breast 65 Basal cell 65 pancreatic lung 65 colon rectum 65 pancreatic prostate 65 breast uterine 65 breast pancreatic 65 rectal cancers 65 prostate breast 65 lung colon 65 prostate pancreatic 65 breast cervical 64 ovarian pancreatic 64 prostate lung 64 Squamous cell 64 bladder ovarian 64 bladder cancers 64 breast endometrial 64 colon prostate 64 leukemia multiple myeloma 64 oesophageal adenocarcinoma 63 breast ovary 63 ovarian cervical 63 colon pancreas 63 colorectum 63 colon breast 63 kidney urologic 63 basal cell carcinoma squamous 63 pancreatic bladder 62 invasive lobular 62 breast prostate 62 castration resistant hormone refractory 62 Renal cell carcinoma 62 deCODE BreastCancer 62 lung malignant melanoma 62 pancreatic cancers 62 colorectal 62 prostate colorectal 62 papillary renal cell carcinoma 62 colorectal ovarian 62 endometrial cancers 61 HPV vaccine protects 61 colorectal gastric 61 endometrial ovarian 61 basal cell carcinoma BCC 61 cervix uteri 61 ovary uterus 61 ductal breast cancer 61 nonmelanoma 61 colon rectal 61 gastric cardia 61 penile cancers 61 Colon polyps 61 serous ovarian cancer 61 colorectal cancers 61 cirrhosis liver failure 61 cervical ovarian 60 pancreatic colon 60 anal cancers 60 skeletal metastases 60 lobular cancer 60 gastric pancreatic 60 gastrointestinal stromal 60 endometrial kidney 60 squamous cell cancers 60 metastatic renal 60 neuroendocrine cancers 60 ovarian colon 60 oesophageal cancers 60 metastatic gastric 60 lung cancers 60 benign noncancerous 60 recurrent metastatic 60 pancreas esophagus 60 nonsmall cell lung cancer 60 deCODE ProstateCancer TM 60 Medullary thyroid cancer 60 metastatic bladder 60 dysplastic lesions caused 60 lung ovarian 60 Glioblastoma multiforme GBM 60 testicular germ cell 60 ovarian endometrial 60 Basal Cell 60 colon pancreatic 60 gynecologic malignancy 59 nasopharyngeal carcinoma 59 chronically immunosuppressed solid 59 gastric cancers 59 lobular breast cancer 59 histologic subtype 59 cutaneous melanoma 59 melanoma basal cell 59 bladder cervix 59 Squamous 59 Epithelial ovarian cancer 59 Colorectal cancer CRC 59 pancreatic ovarian 59 penile anal 59 metastatic HER2 positive 59 lung carcinomas 59 pancreatic adenocarcinoma 59 precursor lesions 59 metastatic breast 59 hormone receptor negative 59 invasive ductal 59 gastrointestinal cancers 59 histologies 59 ovarian colorectal 59 hepatocellular liver 59 colorectal cancer CRC 59 squamous non 59 Uterine cancer 59 Oesophageal cancer 59 stage IIIB IV 59 prostate bladder 59 nonmelanoma skin cancers 59 cancers 59 renal cell carcinomas 59 unresectable tumors 59 hormonally responsive 59 de ath 59 breast ovarian 58 hormonally sensitive 58 castrate resistant 58 cervical uterine 58 Renal Cell Carcinoma RCC 58 Erythropoietic therapies may 58 advanced metastatic renal 58 CYT# potent vascular disrupting 58 squamous cell carcinoma SCC 58 Estrogen receptor positive 58 LHRH receptor positive 58 metastatic pancreatic 58 aerodigestive tract 58 lymphoma myeloma 58 esophageal cancers 58 osteosarcomas 58 leukemia myeloma 58 pancreatic colorectal 58 Malignant melanoma 58 squamous cell skin 58 pancreatic gastric 58 lymphomas leukemias 58 pelvic malignancies 58 chronic periodontitis 58 lobular carcinoma 58 Menopausal hormone therapy 58 diffuse gastric 58 colorectal pancreatic 58 HBeAg negative 58 vulvar cancers 58 Basal cell carcinoma 58 colorectal cancer 58 lobular carcinomas 58 seminoma 58 esophagus pancreas 58 hepatocellular carcinoma liver 58 Her2 positive 58 colorectal liver 58 ductal cancer 58 squamous cell carcinomas 58 Chronic myeloid leukemia CML 58 resistant hormone refractory 58 adenomatous polyps 58 prostate cancer CaP 57 esophagus colon 57 BRCA deficient 57 testicular cancers 57 squamous cell lung cancer 57 deCODE BreastCancer TM 57 gynecologic cancers 57 Benign breast 57 pharyngeal cancer 57 nonmetastatic 57 hematological disorders 57 ovarian uterine 57 Rectal cancer 57 bowel cancers 57 colorectal cancer incidence 57 lung cancer NSCLC 57 uterine cancers 57 Squamous cell carcinomas 57 advanced metastatic prostate 57 metastatic kidney 57 prostate cancers 57 radiosensitive 57 glioma rarer 57 Malignant gliomas 57 squamous 57 Esophageal cancer 57 intrahepatic bile duct 57 advanced adenomas 57 lycopene intake 57 squamous cell cancer 57 malignant neoplasm 57 nasopharyngeal cancer 57 tumor subtypes 57 Human papillomavirus 57 squamous cell 57 atypical hyperplasia 57 carcinoma HCC 57 Pancreatic neuroendocrine tumors 57 tumors GIST 57 lymphoid tumors 57 cisplatin resistant 57 metastatic GIST 57 Acute myeloid leukemia 57 faulty BRCA genes 57 oligodendrogliomas 57 colon cancers 57 adenocarcinomas 57 solar keratosis 57 Human papillomavirus HPV 57 metastatic castrate resistant 57 frequently benign tumor 57 Nonalcoholic fatty liver 57 HNSCC 57 Endometrial cancer 56 Peritoneal mesothelioma 56 precancerous cervical 56 colorectal carcinoma 56 grade gliomas 56 leukaemias 56 cerebrovascular diseases 56 Prostate Cancer Prostate 56 Acute lymphoblastic leukemia 56 nonmelanoma skin cancer 56 premalignant 56 Acute myelogenous leukemia 56 epithelial tumors 56 Metastatic 56 faulty BRCA2 gene 56 ribonucleotide reductase clinically validated 56 metastatic prostate 56 Colorectal cancer 56 pediatric acute lymphoblastic 56 situ LCIS 56 esophageal tumors 56 Cutaneous T 56 malignant brain 56 Brain metastases 56 ovarian cancers 56 tamoxifen Nolvadex ® 56 leukemias lymphomas 56 Carcinoid tumors 56 commercialize deforolimus 56 acute leukemias 56 leukemia lymphoma multiple myeloma 56 gastric adenocarcinoma 56 circulatory diseases 56 advanced hepatocellular carcinoma 56 situ CIS 56 mesotheliomas 56 HER2 amplified 56 tongue mouth pharynx 56 stage IIIb IV 56 gene BRCA2 56 Relapsing remitting MS 56 colon esophageal 56 undergone radical prostatectomy 56 neoplasias 56 biliary tract cancer 56 Gastric cancer 56 medullary thyroid cancer 56 Chronic lymphocytic leukemia CLL 56 BRCA2 mutations 56 beta blockers ACE inhibitors 56 CHD CVD 56 cancerous enlargement 56 Sezary syndrome 56 soft tissue sarcomas 56 gastroesophageal junction 56 HER2 positive cancers 56 emphysema chronic bronchitis 55 sarcomatoid 55 hematological diseases 55 Thyroid nodules 55 EGFR mutation positive 55 candidemia 55 urologic diseases 55 Androgen deprivation therapy 55 hormone refractory metastatic prostate 55 oropharyngeal cancer 55 Leukemias 55 castrate resistant prostate cancer 55 Precancerous 55 recurrent ovarian 55 Coronary heart 55 Evoltra ® 55 HER2 positive breast 55 Chronic lymphocytic leukemia 55 malignancies 55 basal cell skin 55 metastatic androgen independent 55 nonseminoma 55 colorectal adenoma 55 gastric carcinoma 55 nonsquamous histology 55 colorectal neoplasms 55 nonproliferative 55 recurrent NSCLC 55 Helicobacter pylori infection 55 peritoneal cancer 55 Waldenstrom macroglobulinemia 55 cerebrovascular ailments 55 Stomach cancer 55 TTR amyloidosis 55 hepatocellular carcinoma HCC 55 mutated KRAS gene 55 intestinal metaplasia 55 Idiopathic pulmonary fibrosis 55 Stomach stapling 55 malignant cancerous 55 Celiac disease affects 55 epithelial ovarian 55 recurrent glioblastoma multiforme GBM 55 gynecological cancers 55 adenocarcinoma 55 adjuvant therapies 55 liver cancers hypercholesterolemia 55 detecting precancerous 55 cancerdefine 55 Bladder cancer 55 distant metastasis 55 detect precancerous lesions 55 endometrial tumors 55 Alessandro Riva 55 endometrial hyperplasia 55 Radical prostatectomy 55 cervical carcinoma 55 macrovascular events 55 Hepatocellular carcinoma 55 triggers apoptosis programmed 55 carcinomas 55 prostate carcinoma 55 refractory Hodgkin 55 malignant pleural mesothelioma 55 squamous histology 55 malignant growths 55 completely resected 55 multiple sclerosis psoriasis 55 HRPC ovarian cancer 55 colorectal tumors 55 grade serous ovarian 55 Hepatocellular Carcinoma HCC 55 prostate carcinomas 55 Uterine fibroids 55 Homocysteine levels 55 Pneumococcal pneumonia 55 Antibiotic resistant infections 55 Folfox 55 myeloproliferative neoplasms 55 neuroendocrine tumors 55 Acute myeloid leukemia AML 55 common hematologic malignancy 55 Myelodysplastic syndromes 55 carcinoid 55 Colorectal cancers 55 myelofibrosis polycythemia vera 55 medically inoperable 55 transplantation HCT 55 colorectal polyp 54 systemic autoimmune 54 pulmonary metastases 54 histological subtypes 54 thalassemia sickle cell 54 Metastatic breast cancer 54 gastrointestinal stromal tumors GISTs 54 Squamous Cell 54 malignant neoplasms 54 Li Fraumeni 54 rectal cancer 54 Surgical resection 54 Hepatocellular carcinoma HCC 54 dyslipidemia hypertension diabetes 54 nonalcoholic steatohepatitis 54 Papillary 54 cisplatin chemotherapy 54 Vicinium TM 54 lobular involution 54 leukemia Hodgkin 54 basal cell cancer 54 ErbB2 positive 54 androgen independent 54 Venous thromboembolism 54 Glioblastoma multiforme 54 atherothrombosis 54 relapsed leukemia 54 throat esophagus 54 Melanomas 54 seminomas 54 chemotherapy cisplatin 54 adrenocortical cancer 54 esophageal stomach 54 Inflammatory breast cancer 54 glioblastoma multiforme GBM 54 ductal carcinomas 54 non squamous 54 macroglobulinemia 54 cutaneous T 54 refractory colorectal cancer 54 Follicular lymphoma 54 Opportunistic infections 54 Gliomas 54 metastatic renal cell 54 differentiated thyroid 54 benign prostatic hyperplasia enlarged 54 gastric cancer 54 hypertension hypercholesterolemia 54 gynecological malignancies 54 Malignant tumors 54 albiglutide currently 54 diseases fat malabsorption 54 Chronic myeloid leukemia 54 hepatocellular cancer 54 cystic fibrosis chronic pancreatitis 54 Clostridium difficile infections 54 simplex virus 54 hepatocellular carcinomas 54 histological subtype 54 unresectable liver cancer 54 lymphoma Hodgkin lymphoma 54 recurrent colorectal cancer 54 atypical ductal hyperplasia 54 recurrent malignant glioma 54 colon lung 54 communicable chronic 54 biliary cancer 54 CIN3 54 advanced HER2 positive 54 Hodgkin lymphoma HL 54 bronchogenic carcinoma 54 Adjuvant chemotherapy 54 lung adenocarcinomas 54 bile duct cancers 54 gynecological cancer 54 dysplastic nevi 54 HIV HCV coinfected 54 tumor histology 54 lymphoproliferative disorders 54 cancer mCRC 54 treating cancerous tumors 54 HER2 expression 54 hepatocellular carcinoma 54 Sentinel node biopsy 54 KRAS mutant 54 esophageal adenocarcinoma 54 metastatic liver 54 colon rectum breast 54 gallstone disease 54 polyp recurrence 54 tumor metastases 54 Chlamydia trachomatis infection 54 Soft tissue sarcomas 54 del 5q MDS 54 Basal cell carcinomas 54 sickle cell cystic fibrosis 54 oropharyngeal cancers 54 cervical cancers 54 molecular abnormalities 54 lymph node enlargement 54 relapsed MM 54 distal colon cancer 54 Temodar ® 54 advanced adenoma 54 commercializes oncology 54 leiomyomas 54 invasive lobular carcinoma 54 allogeneic HSCT 54 Benign prostatic hyperplasia BPH 54 non Hodgkin lymphomas 54 recurrent myocardial infarction 54 unresectable locally advanced 53 metastatic basal cell 53 epithelioid 53 cardio metabolic diseases 53 advanced medullary thyroid 53 thyroid cancers 53 Vidaza ® 53 signal transduction inhibitors 53 ductal adenocarcinoma 53 BMPR2 53 operable breast cancer 53 decompensated liver disease 53 gastroenterology neurology 53 palliative radiotherapy 53 invasive fungal 53 cell lung cancer 53 pituitary adenomas 53 lung cancer asbestosis 53 testicular tumors 53 benign neoplasms 53 Valvular heart 53 Rheumatoid arthritis affects 53 PLX STROKE targeting 53 nodal metastasis 53 TT genotype 53 cardiovascular disease hypertension 53 oral squamous cell 53 Gardasil protects 53 Malignant glioma 53 small lymphocytic lymphoma 53 Intracerebral hemorrhage 53 colorectal polyps 53 basal cell cancers 53 nonalcoholic steatohepatitis NASH 53 endocrinology gastroenterology 53 malignant ovarian 53 dyslipidemias 53 proliferative disorders 53 Invasive Breast Cancer 53 HER2 overexpression 53 BRCA1 mutation carriers 53 prostate adenocarcinoma 53 lenalidomide Revlimid R 53 non resectable 53 3 carbinol 53 hereditary pancreatitis 53 stem cells CSCs 53 cause mesothelioma asbestosis 53 Kit CD# positive 53 systemic scleroderma 53 precancerous tumors 53 HER2 + 53 grade cervical intraepithelial 53 cell carcinomas 53 investigational immunotherapy 53 carcinoid tumors 53 sorafenib tablets 53 investigational therapies 53 commonest cancers 53 Glioblastomas 53 psoriasis inflammatory bowel 53 colorectal adenomas 53 neoplasms 53 Benign tumors 53 underwent prostatectomy 53 Myelodysplastic syndromes MDS 53 HER2 positive metastatic breast 53 genitourinary tract 53 locoregional recurrence 53 Ovarian Cancers 53 dasatinib Sprycel 53 mycosis fungoides 53 angioplasties stents 53 ASCUS 53 Colorectal cancer screening 53 Fibroid tumors 53 metastatic HER2 negative 53 Adenomas 53 accumulate preferentially 53 peritoneal carcinomatosis 53 Systemic lupus erythematosus SLE 53 unresectable recurrent 53 Polycythemia vera 53 Human papilloma virus 53 GRNOPC1 contains 53 premalignant lesion 53 basal cell 53 Malignant Melanoma 53 finasteride Proscar 53 Non Melanoma Skin 53 novel tubulin binding 53 gynecologic malignancies 53 serogroup B 53 HER2 positive 53 ansamycin 53 atrophic gastritis 53 BRCA mutation carriers 53 cell carcinoma RCC 53 neoadjuvant therapy 53 mucinous 53 invasive bladder 53 benign moles 53 HER2 positive tumors 53 Neurological disorders 53 subependymal giant cell 53 node metastases 53 familial pancreatic cancer 53 Ischaemic heart 53 pancreatic NET 53 vaginal lesions 53 Metastatic colorectal cancer 53 superficial basal cell carcinoma 53 lupus scleroderma 53 Radiofrequency ablation 53 urinary bladder cancer 53 Bowel cancer 53 hormone therapy estrogen 53 advanced epithelial ovarian 53 invasive ductal carcinoma 53 pancreatic islet cell 53 Cancer Incidence Mortality 53 Lung cancer 53 GISTs 53 monoclonal antibody therapies 53 hereditary predisposition 53 Chlamydia infection 53 Cholangiocarcinoma 53 BRCA1 BRCA2 52 Glioblastoma Multiforme GBM 52 inherited metabolic disorders 52 Lymphomas 52 gastric atrophy 52 lymphoma leukemia 52 relapsed acute lymphoblastic 52 MCF7 52 anaplastic 52 IgG1 monoclonal antibody 52 anal lesions 52 intra abdominal abscess 52 uveal melanoma 52 Indians Alaskan Natives 52 invasive carcinoma 52 chronic thromboembolic pulmonary 52 Shark cartilage 52 Glioblastoma Multiforme 52 vinca alkaloids 52 neurovascular diseases 52 cardio vascular disease 52 mutated K ras 52 ZACTIMA 52 cervical intraepithelial neoplasia 52 refractory metastatic 52 ovarian carcinoma 52 colorectal bowel 52 coinfected 52 Tay Sachs thalassemia 52 vulvar cancer 52 oncological indications 52 diphtheria pertussis whooping cough 52 malignant lymphomas 52 primary hyperparathyroidism 52 postmenopausal hormone 52 epithelial cancers 52 heavily pretreated 52 develop premenopausal breast 52 invasive candidiasis 52 breast cancer susceptibility genes 52 Inflammatory bowel disease 52 hepatorenal syndrome 52 mesothelioma asbestosis 52 KRAS mutations occur 52 Pneumococcal infections 52 SSc 52 adenomatous 52 chemo resistant 52 cirrhosis liver cancer 52 bacterial prostatitis 52 antitumor effect 52 advanced unresectable 52 bone metastasis 52 pulmonary metastasis 52 malignant polyps 52 non squamous NSCLC 52 Dental caries 52 oropharyngeal squamous cell carcinoma 52 Salvatore Glorioso mayor 52 invasive ductal breast cancer 52 breast carcinoma 52 Hurthle cell 52 metastatic neuroendocrine tumors 52 Adenocarcinoma 52 KRAS oncogene 52 Non Alcoholic Fatty 52 melanoma skin 52 renal carcinoma 52 cytotoxic therapies 52 urological cancers 52 recurrent glioblastoma multiforme 52 hematologic diseases 52 distal colon 52 diabetes hyperlipidemia 52 Syncria R 52 Afatinib 52 myelofibrosis MF 52 malignant pancreatic 52 cell carcinoma 52 prostate cancer CRPC 52 Squamous cell cancer 52 angiotensin receptor blockers ARB 52 metastatic medullary thyroid 52 acute myeloid 52 cholangiocarcinoma 52 myocardial infarction stroke 52 cardio vascular diseases 52 Cell Lung Cancer 52 grade cervical dysplasia 52 vinca alkaloid 52 produces radioisotopes 52 haematologic malignancies 52 hormone refractory 52 underarm lymph nodes 52 human papillomaviruses HPV 52 cytoreduction 52 Glioma 52 MYH9 gene 52 clinically localized prostate 52 Non Hodgkins lymphoma 52 liver metastasis 52 Digital Mammographic Imaging 52 BCG refractory 52 endometrioid 52 immune modulators 52 microsphere therapy 52 polyps growths 52 Candida infections 52 recurrent coronary 52 overt hepatic encephalopathy HE 52 fibrocystic disease 52 NMIBC 52 idiopathic myelofibrosis 52 ixabepilone 52 relapsed ALL 52 intracranial atherosclerosis 52 stage IIIA 52 HER2 negative 52 haematological malignancies 52 Acute coronary syndromes 52 AI AN 52 rituximab refractory follicular 52 lymphatic cancers 52 AML MDS 52 Pleural mesothelioma 52 hematologic disorders 52 dysglycemia 52 asbestosis mesothelioma 52 thromboembolic disease 52 metastatic castration resistant 52 PCNSL 52 induce apoptosis programmed 52 Colorectal 52 Ectopic pregnancy 52 erlotinib Tarceva ® 52 Anal cancer 52 MELD scores 52 treat enlarged prostate 52 asthmas 52 histologic subtypes 52 refractory gastrointestinal stromal 52 leukemia AML 52 often detect precancerous 52 cervical lymph nodes 52 FUSILEV enhances 52 noncancer 52 chemotherapeutic regimens 52 Candida infection 52 Folate deficiency 52 carotid plaques 52 abnormal pap smears 52 serum GGT 52 Vandetanib 52 anthracycline taxane 52 pleural mesothelioma 51 meningiomas 51 neuroendocrine carcinoma 51 Darapladib 51 GBMs 51 papillary 51 RET PTC rearrangements 51 schwannomas 51 esophagus larynx 51 radiation chemoradiation 51 BRCA2 carriers 51 curable cancers 51 urothelial bladder cancer 51 non hodgkin lymphoma 51 contralateral breast 51 chemopreventive agents 51 symptomatic BPH 51 gonococcal infections 51 basal cell nevus syndrome 51 Sexually transmitted infections STIs 51 colorectal neoplasia 51 chlamydial infection 51 receptor tyrosine kinase inhibitor 51 external genital lesions 51 Plasmodium falciparum malaria 51 hormone gastrin 51 Multiple myeloma MM 51 MabThera Rituxan 51 squamous cell carcinoma 51 Phase #b/#a clinical 51 relapsed SCLC 51 neurologic complications 51 abnormal Pap smears 51 adenomatous polyp 51 BRCA1 mutations 51 ImmunoGen DM1 cancer 51 refractory chronic lymphocytic 51 Globocan 51 lung adenocarcinoma 51 metastatic adenocarcinoma 51 prostate TURP 51 ocular disorders 51 benign proliferative breast 51 relapsing remitting MS RRMS 51 atherosclerotic cardiovascular 51 metastatic lymph nodes 51 HER2 positive breast cancer 51 Non Hodgkin lymphomas 51 Prostate Lung Colorectal 51 biliary tract cancers 51 oral cavity pharynx 51 cytotoxics 51 beta carotene supplementation 51 Zolinza 51 papillomaviruses 51 hypereosinophilic syndrome 51 esophageal squamous cell carcinoma 51 uterine tumors 51 Bayer Nexavar 51 PROLARIS 51 axillary lymph nodes 51 Meningiomas 51 neoplastic lesions 51 resuscitated cardiac arrest 51 doublet chemotherapy 51 neck squamous cell 51 Anaplastic 51 hormone deprivation 51 abnormal Pap tests 51 cutaneous T cell 51 MAGE A3 ASCI 51 antimetabolites 51 antiproliferative effects 51 Respiratory syncytial virus RSV 51 B Cell Lymphoma 51 intravenous bisphosphonates 51 radiofrequency ablation RFA 51 chronic myeloid 51 minimally symptomatic 51 Apaziquone 51 smoldering myeloma 51 lymphomas 51 benign breast 51 hematopoietic cancers 51 bacterial sexually transmitted 51 liver scarring 51 oncologic diseases 51 Myelodysplastic syndrome 51 venous blood clots 51 leukemia APL 51 Study Tanning beds 51 unresectable stage 51 fatty breasts 51 gastrointestinal mucositis 51 endocrine therapies 51 Nutrition EPIC 51 Alzheimer disease vascular dementia 51 Hepatocellular Carcinoma 51 Merck KGaA Erbitux 51 undergo radical prostatectomy 51 vaginal cancers 51 lignan intake 51 infectious diseases autoimmune diseases 51 colonic polyps 51 HPV genotypes 51 causes genital warts 51 BRCA mutations 51 urothelial carcinoma 51 fibrocystic 51 intestinal polyps 51 obstructive coronary artery 51 thrombo embolic 51 follicular thyroid cancer 51 Rotavirus causes 51 chronic HBV 51 colon tumors 51 proximal colon 51 brivanib 51 relapsed Acute Myeloid 51 evaluating picoplatin 51 nonfatal cardiac arrest 51 venous thromboembolic events 51 metachronous 51 Soft Tissue Sarcoma 51 Osteoporosis affects 51 docetaxel Taxotere ® 51 CLL SLL 51 erythematosus 51 neoadjuvant treatment 51 Virulizin ® 51 dermatofibrosarcoma protuberans 51 Routine screening 51 tumor xenograft models 51 relapsed ovarian cancer 51 malignant gliomas 51 thyroid nodules 51 Chronic Lymphocytic Leukemia CLL 51 Extensively drug 51 fallopian tube carcinoma 51 IMC #B 51 myeloproliferative disorders 51 hematologic malignancies 51 pre cancerous growths 51 chronic eosinophilic leukemia 51 Peripheral artery 51 pheochromocytoma 51 CHD mortality 51 thyroid carcinomas 51 antiplatelet medications 51 Peginterferon alfa 2b 51 precancerous condition 51 SIR Spheres microspheres 51 locoregional 51 Hepatocellular 51 cutaneous squamous cell carcinoma 51 Acetaminophen overdose 51 Cerebral malaria 51 Parasitic worms 51 Pap smear screening 51 Urinary incontinence affects 51 chronic prostatitis 51 breast cancer subtypes 51 thyroid carcinoma 51 repeat revascularization 51 progesterone receptor negative 51 gemcitabine chemotherapy 51 antioxidant flavonoids 51 gefitinib Iressa 51 Human cl 51 Bone metastases 51 ductal lobular 51 neural tube birth defects 51 Screening mammograms 51 Synovial sarcoma 51 prednisone prednisolone 51 gastrointestinal stromal tumor 51 Zyclara Cream 51 HER2 ErbB2 51 metastatic relapsed 51 lung cancer mesothelioma 51 carcinoma HNSCC 51 chlamydial infections 51 renal tumors 51 precancers 51 Multiple myeloma 51 Elevated CRP 51 urethritis 51 ABCB1 51 CP CPPS 51 Cell Non Hodgkin 51 monoclonal antibody conjugated 51 neoplastic 51 Squamous Cell Carcinoma 51 cervical vaginal 50 H. pylori eradication 50 Chronic hepatitis B 50 incurable prostate 50 colon adenomas 50 imatinib Gleevec 50 medulloblastoma tumors 50 mTOR inhibitors 50 pheochromocytomas 50 metastatic carcinoma 50 immunocompromised individuals 50 Squamous cell carcinoma 50 metastatic melanomas 50 CVD mortality 50 Cystic fibrosis affects 50 Stage IIIb 50 Bloodstream infections 50 basal cell carcinomas 50 follicular lymphoma FL 50 relapsed refractory AML 50 lymph node removal 50 PSADT 50 Cloretazine 50 hyperhomocysteinemia 50 urothelial cancer 50 Systemic lupus erythematosus 50 Acute lymphocytic leukemia 50 myeloproliferative diseases 50 cryptococcosis 50 malignant lymphoma 50 neoplasia 50 hormone receptor positive 50 osteosarcoma rare 50 melanoma lesions 50 Sjögren syndrome 50 Zinc deficiency 50 recurrent squamous cell carcinoma 50 chronic HBV infection